MCL-1 INHIBITORS

The present disclosure generally relates to compounds and pharmaceutical compositions that may be used in methods of treating cancer. 本发明总体上涉及化合物和药物组合物,其可用于治疗癌症的方法。

Saved in:
Bibliographic Details
Main Authors WATKINS WILLIAM J, HWANG TAE H, HURTLEY ANNA E, SQUIRES NEIL H, TSUI VICKIE H, CHU HANG, NEWBY ZACHARY, KOBAYASHI TETSUYA, LI XIAOFEN, LIN DAVID W, VENKATARAMANI CHANDRASEKAR, LAZERWITH SCOTT E, KATO DARRYL, MITCHELL MICHAEL L, YANG HONG, GUERRERO JUAN A, JIANG LAN, MEDLEY JONATHAN W, KNOX JOHN E, NADUTHAMBI DEVAN
Format Patent
LanguageChinese
English
Published 22.12.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present disclosure generally relates to compounds and pharmaceutical compositions that may be used in methods of treating cancer. 本发明总体上涉及化合物和药物组合物,其可用于治疗癌症的方法。
Bibliography:Application Number: CN201980032695